This week FSA presents a quick comparison of two China equity products: the Allianz China A-Shares Fund and the Schroder ISF China A Fund.
The country’s worst covid outbreak is causing disruption to the economy.
FSA compares two China equity products: the Allianz China A Shares Fund and the FSSA Greater China Growth Fund.
This week FSA presents a quick comparison of two China Equity products: the Ninety One All China Equity Fund and the Schroder ISF All China Equity Fund.
Investors should focus on beneficiaries of China’s new growth model.
The Boston-based firm sees the Sino-US rivalry and China’s regulatory tightening as major risks in the country.
The asset manager believes China is still “investable” and its tech companies provide good opportunities.
There are quality companies in China in sectors less impacted by regulation, according to Vontobel Asset Management.
Uncertainty has created discounted investment opportunities for stock pickers, according to Fidelity International.
With leading indicators for China suggesting only a temporary economic slowdown, there is reason for optimism in terms of the fixed income and equity markets, according to Pictet Asset Management (Pictet AM).